PathMaker Neurosystems Receives FDA Breakthrough Device Designation For Use of the MyoRegulator® Neuromodulation Device in ALS For Slowing the Progression of Functional Symptoms

PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neurotechnology company developing a breakthrough non-invasive approach for treating Amyotrophic Lateral Sclerosis (ALS, Lou Gehrig’s ...
ALS News Today

Device for slowing ALS progression wins FDA breakthrough status

MyoRegulator, a device to be used at home to slow disability progression in ALS, has been granted breakthrough device ...
Yahoo Finance

PathMaker Neurosystems Announces Initiation of First-in-Human Trial in ALS for Non-Invasive Neuromodulation Device

BOSTON and PARIS, Sept. 14, 2023 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the ...
Purdue University

Pathmaker Internship Program™

There is no program at Purdue that I'm more excited about. An internship gives students experience and exposure, but most importantly, real world practice in their chosen field of study. All evidence, ...
WNCT

PathMaker Neurosystems Announces Publication of First Study Demonstrating Increased Survival in an ALS Mouse Model After Treatment With Non-Invasive Neuromodulation

Boston, MA and Providence, RI, July 07, 2025 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neurotechnology company developing a breakthrough non-invasive approach for ...
Purdue University

Indiana companies expand Purdue Pathmaker Internship Program

WEST LAFAYETTE, Ind. – Purdue University senior Miranda Lung admits to being surprised by how much she has been learning in her internship at Lafayette, Indiana-based Wabash National Corp. "I've been ...
manilatimes

PathMaker Neurosystems Announces IRB Approval for DoD-funded Clinical Trial of the MyoRegulator Device in ALS

BOSTON, Feb. 04, 2025 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. ("PathMaker”), a clinical-stage neuromodulation company developing a breakthrough non-invasive approach to the treatment of ALS, ...